Aspirin, Dipyridamole Drug Combination

A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.

Year introduced: 2016 (1986)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D02.455.426.559.389.657.410.595.176.500, D03.383.742.175.500, D26.310.125

MeSH Unique ID: D000068342

Entry Terms:

• Aspirin-Dipyridamole Drug Combination
• Aspirin Dipyridamole Drug Combination
• Combination, Aspirin-Dipyridamole Drug
• Drug Combination, Aspirin-Dipyridamole
• Asasantin
• TX 3301
• 3301, TX
• TX-3301
• Aggrenox
• Extended-Release Dipyridamole-Aspirin
• Dipyridamole-Aspirin, Extended-Release
• Extended Release Dipyridamole Aspirin
• Asasantin Retard
• Retard, Asasantin

Pharmacologic Action:

• Platelet Aggregation Inhibitors

All MeSH Categories
Chemicals and Drugs Category
Organic Chemicals
Hydrocarbons
Hydrocarbons, Cyclic
Hydrocarbons, Aromatic
Benzene Derivatives
Phenols
Hydroxybenzoates
Salicylates
Aspirin
Aspirin, Dipyridamole Drug Combination

All MeSH Categories
Chemicals and Drugs Category
Heterocyclic Compounds
Heterocyclic Compounds, 1-Ring
Pyrimidines
Dipyridamole
Aspirin, Dipyridamole Drug Combination

All MeSH Categories
Chemicals and Drugs Category
Pharmaceutical Preparations
Drug Combinations
Aspirin, Dipyridamole Drug Combination